{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:56:31Z","timestamp":1781805391036,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40121-026-01367-8","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:34:40Z","timestamp":1780529680000},"page":"1995-2008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Micafungin Sequestration and Late Release During Continuous Renal Replacement Therapy with Polyacrylonitrile- and Polysulfone-Derived Filters"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5767-4441","authenticated-orcid":false,"given":"Julien","family":"Massol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Maulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jullien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Corriol-Rohou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Herl\u00e9","family":"Raphalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric J.","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Lamhaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"1367_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","volume":"23","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Giacobbe DR, Vena A, et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care. 2019;23:219.","journal-title":"Crit Care"},{"key":"1367_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","volume":"45","author":"I Martin-Loeches","year":"2019","unstructured":"Martin-Loeches I, Antonelli M, Cuenca-Estrella M, et al. ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019;45:789\u2013805.","journal-title":"Intensive Care Med"},{"key":"1367_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00134-025-07793-5","volume":"51","author":"JA Roberts","year":"2025","unstructured":"Roberts JA, Sime FB, Lipman J, et al. Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units\u2014the SAFE-ICU study. Intensive Care Med. 2025;51:302\u201317.","journal-title":"Intensive Care Med"},{"key":"1367_CR4","doi-asserted-by":"publisher","first-page":"e01398","DOI":"10.1128\/AAC.01398-17","volume":"61","author":"JM Boonstra","year":"2017","unstructured":"Boonstra JM, van der Elst KC, Veringa A, et al. Pharmacokinetic properties of micafungin in critically ill patients diagnosed with invasive candidiasis. Antimicrob Agents Chemother. 2017;61:e01398-e1417.","journal-title":"Antimicrob Agents Chemother"},{"key":"1367_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jac\/dkw352","volume":"72","author":"V Jullien","year":"2017","unstructured":"Jullien V, Azoulay E, Schwebel C, et al. Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation. J Antimicrob Chemother. 2017;72:181\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1367_CR6","doi-asserted-by":"publisher","first-page":"17741","DOI":"10.1038\/s41598-019-53093-6","volume":"9","author":"S Gastine","year":"2019","unstructured":"Gastine S, Lanckohr C, Blessou M, et al. Pharmacokinetics of micafungin in critically ill patients. Sci Rep. 2019;9:17741.","journal-title":"Sci Rep"},{"key":"1367_CR7","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/jphp.13353","volume":"72","author":"I Kapralos","year":"2020","unstructured":"Kapralos I, Mainas E, Neroutsos E, et al. Population pharmacokinetics of micafungin over repeated doses in critically ill patients: a need for a loading dose? J Pharm Pharmacol. 2020;72:1750\u201360.","journal-title":"J Pharm Pharmacol"},{"key":"1367_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13054-019-2526-2","volume":"23","author":"PM Honor\u00e9","year":"2019","unstructured":"Honor\u00e9 PM, De Bels D, Attou R, Redant S, Gallerani A, Kashani K. Adsorption and caspofungin dosing during continuous renal replacement therapy. Crit Care. 2019;23:240.","journal-title":"Crit Care"},{"key":"1367_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/cc13803","volume":"18","author":"FJ Gonz\u00e1lez de Molina","year":"2014","unstructured":"Gonz\u00e1lez de Molina FJ, Mart\u00ednez-Alberici M, Ferrer R. Treatment with echinocandins during continuous renal replacement therapy. Crit Care. 2014;18:218.","journal-title":"Crit Care"},{"key":"1367_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3389\/fphar.2020.00786","volume":"11","author":"L Li","year":"2020","unstructured":"Li L, Li X, Xia Y, et al. Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy. Front Pharmacol. 2020;11:786.","journal-title":"Front Pharmacol"},{"key":"1367_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10096-004-1228-z","volume":"23","author":"U Theuretzbacher","year":"2004","unstructured":"Theuretzbacher U. Pharmacokinetics\/pharmacodynamics of echinocandins. Eur J Clin Microbiol Infect Dis. 2004;23:805\u201312.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1367_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02425-16","volume":"61","author":"MG Vossen","year":"2017","unstructured":"Vossen MG, Knafl D, Haidinger M, et al. Micafungin plasma levels are not affected by continuous renal replacement therapy: experience in critically ill patients. Antimicrob Agents Chemother. 2017;61:e02425-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"1367_CR13","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1128\/AAC.00335-13","volume":"57","author":"S Weiler","year":"2013","unstructured":"Weiler S, Seger C, Pfisterer H, et al. Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy. Antimicrob Agents Chemother. 2013;57:4053\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1367_CR14","volume":"40","author":"FJ Baud","year":"2021","unstructured":"Baud FJ, Jullien V, Secr\u00e9tan PH, Houz\u00e9 P, Lamhaut L. Are we correctly treating invasive candidiasis under continuous renal replacement therapy with echinocandins? Preliminary in vitro assessment. Anaesth Crit Care Pain Med. 2021;40:100640.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"1367_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107007","volume":"62","author":"FJ Baud","year":"2023","unstructured":"Baud FJ, Jullien V, Desnos-Ollivier M, Lamhaut L, Lortholary O. Caspofungin sequestration in a polyacrylonitrile-derived filter: increasing the dose does not mitigate sequestration. Int J Antimicrob Agents. 2023;62:107007.","journal-title":"Int J Antimicrob Agents"},{"key":"1367_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/aor.12982","volume":"42","author":"P Kolbinger","year":"2018","unstructured":"Kolbinger P, Gruber M, Roth G, Graf BM, Ittner KP. Filter adsorption of anidulafungin to a polysulfone-based hemofilter during CVVHD in vitro. Artif Organs. 2018;42:200\u20137.","journal-title":"Artif Organs"},{"key":"1367_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1051\/ject\/201749150","volume":"49","author":"KM Watt","year":"2017","unstructured":"Watt KM, Cohen-Wolkowiez M, Williams DC, et al. Antifungal extraction by the extracorporeal membrane oxygenation circuit. J Extra Corpor Technol. 2017;49:150\u20139.","journal-title":"J Extra Corpor Technol"},{"key":"1367_CR18","unstructured":"Caspofungin - direct healthcare professional communication (DHPC). European Medicines Agency. 2025."},{"key":"1367_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1177\/0391398820911928","volume":"43","author":"FJ Baud","year":"2020","unstructured":"Baud FJ, Houz\u00e9 P, Raphalen JH, et al. Diafiltration flowrate is a determinant of the extent of adsorption of amikacin in renal replacement therapy using the ST150\u00ae-AN69 filter: an in vitro study. Int J Artif Organs. 2020;43:758\u201366.","journal-title":"Int J Artif Organs"},{"key":"1367_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.therap.2020.10.005","volume":"76","author":"FJ Baud","year":"2021","unstructured":"Baud FJ, Houz\u00e9 P, Carli P, Lamhaut L. Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy: an in vitro assessment. Therapie. 2021;76:415\u201324.","journal-title":"Therapie"},{"key":"1367_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/0391398820976144","volume":"44","author":"FJ Baud","year":"2021","unstructured":"Baud FJ, Jullien V, Abarou T, et al. Elimination of fluconazole during continuous renal replacement therapy: an in vitro assessment. Int J Artif Organs. 2021;44:453\u201364.","journal-title":"Int J Artif Organs"},{"key":"1367_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0140-6736(00)02430-2","volume":"356","author":"C Ronco","year":"2000","unstructured":"Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356:26\u201330.","journal-title":"Lancet"},{"key":"1367_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jchromb.2017.01.036","volume":"1046","author":"B Toussaint","year":"2017","unstructured":"Toussaint B, Lanternier F, Woloch C, et al. An ultra performance liquid chromatography-tandem mass spectrometry method for the therapeutic drug monitoring of isavuconazole and seven other antifungal compounds in plasma samples. J Chromatogr B Anal Technol Biomed Life Sci. 2017;1046:26\u201333.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"1367_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/jpp\/rgab157","volume":"74","author":"K Yamasaki","year":"2022","unstructured":"Yamasaki K, Sakurama K, Nishi K, et al. An in-vitro comparative study of the binding of caspofungin and micafungin to plasma proteins. J Pharm Pharmacol. 2022;74:88\u201393.","journal-title":"J Pharm Pharmacol"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01367-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01367-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01367-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:33:08Z","timestamp":1781803988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01367-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1367"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01367-8","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Julien Massol, Solange Corriol-Rohou, Vincent Jullien, Olivier Lortholary,\u00a0Lionel Lamhaut and Jean-Herl\u00e9 Raphalen have nothing to disclose. Valentin Maulet\u00a0and Fr\u00e9d\u00e9ric J Baud, are shareholders of NeckEpur.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethical approval was not sought for this study, as the work did not involve human participants, human data, or animal subjects. The study was performed entirely in vitro using synthetic materials, which do not fall under the purview of the local ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}